• Endocrine-Oncology Program

    At Dana-Farber/Boston Children's Cancer and Blood Disorders Center, we are committed to providing exceptional care for children with endocrine tumors. Our Endocrine-Oncology Program brings together experts in Endocrinology, Oncology, Surgery, and Cancer Genetics, to provide exceptional, coordinated care to patients diagnosed with endocrine tumors. Because we are one of the largest pediatric cancer centers in the world, our specialists develop a deeper expertise in each sub-type of endocrine tumor, than is possible at most other cancer centers.

    Our Endocrine-Oncology Program has the expertise to diagnose and treat a wide range of tumors and conditions, including:

    • Neuroendocrine tumors
    • Adrenal tumors
    • Tumors of the pancreas
    • Paragangliomas/pheochromocytomas
    • Carcinoid tumors
    • Multiple endocrine neoplasia (MEN)
    • Carney triad/Carney complex
    • Thyroid carcinoma*

    * Children with thyroid carcinoma are treated by an integrated multi-disciplinary team in the Boston Children's Hospital’s Thyroid Program.

    How We Diagnose Endocrine Tumors

    Our pediatric oncologists may order a number of different tests to determine the type and location of the tumor. In addition to a medical history and physical examination, diagnostic procedures may include imaging tests- including MRI, PET and/or CT scan- biopsy, or blood tests, as well as specialized tests based on the type of tumor suspected.

    How We Treat Endocrine Tumors

    Treatments for endocrine tumors are based on the type, location and size of the tumor, the child’s age, overall health and medical history, the extent of disease, and the doctor’s expectations for how the tumor will behave. Surgery is used to treat many endocrine tumors. Chemotherapy may be used to kill off cancer cells.

    Our Endocrine-Oncology Team

    We use a multidisciplinary approach to patient care and work closely to coordinate our efforts with the Divisions of Pediatric Oncology, Surgery, and Endocrinology.

    Junne Kamihara, MD, PhD
    Pediatric Oncology, Pediatric Cancer Genetic Risk Program

    Dr. Kamihara received her medical degree from Harvard Medical School and her PhD in genetics from MIT. She completed her pediatric residency training at Boston Children's Hospital and her fellowship in pediatric hematology/oncology at the Dana-Farber Cancer Institute and Boston Children's Hospital. She is currently an attending physician at Dana-Farber/Boston Children's in Pediatric Oncology. Her research and clinical interests focus on pediatric cancer predisposition syndromes.

    Brent R. Weil, MD
    Surgical Oncology

    Dr. Weil received his medical degree from Ohio State University School of Medicine. He completed his surgical residency training at Indiana University School of Medicine and his fellowship in pediatric general surgery at Boston Children's Hospital. He is currently an attending physician at Dana-Farber/Boston Children's and in the Department of Surgery at Boston Children's Hospital. His research and clinical interests focus on pediatric surgical oncology.

    Ari J. Wassner, MD
    Endocrinology

    Dr. Wassner attended Harvard Medical School and completed residency training in Pediatrics, at Boston Children's Hospital, where he also served as Chief Resident. He subsequently completed a subspecialty fellowship training in Pediatric Endocrinology at Boston Children's Hospital.

    The Endocrine-Oncology team also includes a dedicated nurse practitioner and genetic counselors:

    • Jill Brace O'Neill, MS, PPCNP-BC – Pediatric Nurse Practitioner
    • Sarah Cochrane, MS, LGC – Genetic Counselor
    • Jaclyn Schienda, ScM, LGC – Genetic Counselor
    • Katherine Schneider, MPH, LGC – Genetic Counselor
    • Becca Vanderwall, MS, MPH, LGC – Genetic Counselor

    Endocrine Tumor Research and Clinical Trials

    Children who are treated through our Endocrine-Oncology Program benefit from the work of our basic and clinical researchers, who are striving to understand the scientific causes of endocrine cancers, which results in the introduction of new treatment options. We are a world leader in translational research, bringing laboratory advances to the bedside and into doctors' offices as quickly as possible.

  • Top Ranked for Cancer Care

    U.S. News Best Children's Hospitals logoWorld class cancer care at the #1 Children's Hospital

  • Solid Tumor Clinical Trials

    Through research and clinical trials, we are developing innovative therapies and helping to improve treatment for solid tumors.callout bg